Esperion Therapeutics Inc
(LTS:0IIM)
$
2.135
0.1668 (8.47%)
Market Cap: 424.83 Mil
Enterprise Value: 504.66 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 50/100 Esperion Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 02:15PM GMT
Release Date Price:
$22.88
(+3.46%)
Olivia Simone Brayer
BofA Securities, Research Division - Associate
All right. Good morning, everyone, and welcome to our final day of our BofA Virtual Vegas Healthcare Conference. My name is Olivia Brayer, and I'm on the U.S. Biopharma team here at Bank of America. And we're very happy to have with us today, Chief Operating Officer of Esperion Therapeutics, Sheldon Koenig. Thanks so much for being with us today, Sheldon.
Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director
Thanks, Olivia. Great to be here.
Olivia Simone Brayer
BofA Securities, Research Division - Associate
Yes. So let me turn it over to you to go over to some slides and just the broader overall Esperion story.
Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director
Will do. Thanks, Olivia, and good morning, everybody, and thank you so much. It's a pleasure to be here representing the team for Esperion. We have an exciting and compelling story. And I'll
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot